Literature DB >> 15465410

Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections.

Sumalee Chanama1, Surapee Anantapreecha, Atchareeya A-nuegoonpipat, Areerat Sa-gnasang, Ichiro Kurane, Pathom Sawanpanyalert.   

Abstract

BACKGROUND: Dengue viruses are a serious cause of illness in tropical and subtropical areas of the world. Laboratory diagnosis is essential for confirmation of dengue virus infections. Detection of specific IgM by IgM-capture enzymed-linked immunoassay (ELISA) has been widely used as a main serological diagnostic technique.
OBJECTIVES: The levels of specific IgM in secondary dengue virus infections were compared with those in primary infections. STUDY
DESIGN: A total of 1780 samples collected from 924 confirmed dengue cases were tested for anti-dengue IgM by IgM-capture ELISA. RESULTS AND
CONCLUSIONS: Specific IgM was detected in all the cases with primary dengue virus infection on disease day 9 or later. However, specific IgM cannot be detected in 28% (204/716) of the cases in secondary infections. The average titers of IgM were higher in primary infections than in secondary infections. The results confirmed that IgM detection is a reliable serological diagnostic test in primary dengue virus infections. Although IgM detection is also a useful test, other serological diagnostic tests or tests for dengue virus detection are necessary for confirmation of all the secondary dengue virus infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465410     DOI: 10.1016/j.jcv.2004.03.005

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  32 in total

Review 1.  Dengue: a continuing global threat.

Authors:  Maria G Guzman; Scott B Halstead; Harvey Artsob; Philippe Buchy; Jeremy Farrar; Duane J Gubler; Elizabeth Hunsperger; Axel Kroeger; Harold S Margolis; Eric Martínez; Michael B Nathan; Jose Luis Pelegrino; Cameron Simmons; Sutee Yoksan; Rosanna W Peeling
Journal:  Nat Rev Microbiol       Date:  2010-12       Impact factor: 60.633

2.  Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  A Sa-Ngasang; S Anantapreecha; A A-Nuegoonpipat; S Chanama; S Wibulwattanakij; K Pattanakul; P Sawanpanyalert; I Kurane
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  Development of a more efficient algorithm for identifying false-positive reactivity results in a dengue virus immunoglobulin M screening assay.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

4.  Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Authors:  Gerson Dierley Keppeke; Minoru Satoh; Maria Lucia Gomes Ferraz; Edward K L Chan; Luís Eduardo C Andrade
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

5.  Development and Performance of Dengue Diagnostic Clinical Algorithms in Colombia.

Authors:  Diana María Caicedo-Borrero; José Rafael Tovar; Andrés Méndez; Beatriz Parra; Anilza Bonelo; Jairo Celis; Liliana Villegas; Constanza Collazos; Lyda Osorio
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

6.  Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated.

Authors:  Andrew K I Falconar; Elsa de Plata; Claudia M E Romero-Vivas
Journal:  Clin Vaccine Immunol       Date:  2006-09

7.  Prospective study to determine accuracy of rapid serological assays for diagnosis of acute dengue virus infection in Laos.

Authors:  Stuart D Blacksell; David Bell; James Kelley; Mammen P Mammen; Robert V Gibbons; Richard G Jarman; David W Vaughn; Kemajittra Jenjaroen; Ananda Nisalak; Soulignasack Thongpaseuth; Manivanh Vongsouvath; Viengmone Davong; Phonelavanh Phouminh; Rattanaphone Phetsouvanh; Nicholas P J Day; Paul N Newton
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

8.  Dengue incidence in urban and rural Cambodia: results from population-based active fever surveillance, 2006-2008.

Authors:  Sirenda Vong; Virak Khieu; Olivier Glass; Sowath Ly; Veasna Duong; Rekol Huy; Chantha Ngan; Ole Wichmann; G William Letson; Harold S Margolis; Philippe Buchy
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

9.  Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards.

Authors:  Mark E Beatty; Amy Stone; David W Fitzsimons; Jeffrey N Hanna; Sai Kit Lam; Sirenda Vong; Maria G Guzman; Jorge F Mendez-Galvan; Scott B Halstead; G William Letson; Joel Kuritsky; Richard Mahoney; Harold S Margolis
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

10.  Development of Zika Virus Serological Testing Strategies in New York State.

Authors:  William T Lee; Susan J Wong; Karen E Kulas; Alan P Dupuis; Anne F Payne; Laura D Kramer; Amy B Dean; Kirsten St George; Jennifer L White; Jamie N Sommer; Michel Ledizet; Ronald J Limberger
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.